Although the growing interest in PON1 has been so far focused in cardio-metabolic outcomes, there is evidence that suggests that PON1 genotype and enzyme activity is associated with adult neurological diseases such as Parkinson and Alzheimer48. This evidence concerns the gene PON1 and nervous system disorder.